PresseBox - 512.424 Pressemitteilungen, 26.015 Pressefächer
Suche Detailsuche

Meldungen sortieren nach Relevanz Meldungsdatum

vorherige Seite vorherige Seite 123 nächste Seite nächste Seite
Ergebnisse 1 - 15 von 42

BioTeSys selects Logos Technologies ALPHADAS eSource and pro-active EDC system to give clients real time access to study data

, Biotechnik, BioTeSys GmbH

Logos Technologies, the leading provider of EDC & CTMS solutions to the early phase clinical trial marketplace today announced that BioTeSys has chosen the market...

Xenon-Sapphire: New 16k line scan lenses from SCHNEIDER KREUZNACH

, Optische Technologien, Jos. Schneider Optische Werke GmbH

At VISION 2011 in Stuttgart, Schneider-Kreuznach is showing its new Xenon-Sapphire special lens. This lens series is designed for the highest requirements of web...

Imperva Redefines Web Application Security with Powerful Fraud Prevention and Bot Protection

, Sicherheit, Imperva Inc.

Imperva, a pioneer and a leader of a new category of data security solutions for high-value business data in the data center, announced today the availability of...

AiCuris: No Resistant Herpes Simplex Virus (HSV) Observed in Phase II Trial with Herpes Drug AIC316

, Forschung und Entwicklung, AiCuris GmbH & Co. KG

B3C newswire / - AiCuris announces today that it will present the results of the resistance analysis from the recently completed phase II clinical trial with AIC316...

AiCuris' HCMV Drug Letermovir (AIC246) Receives Fast Track from FDA

, Forschung und Entwicklung, AiCuris GmbH & Co. KG

AiCuris announced today that the Food and Drug Administration (FDA) of the United States has granted Fast Track designation for one of the company's lead drugs,...

SuppreMol employs Protagen biomarkers in SLE study

, Medizintechnik, Protagen AG

SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases and allergies, and Protagen...

AiCuris' Novel HSV Compound AIC316 Shows Efficacy in Phase II

, Forschung und Entwicklung, AiCuris GmbH & Co. KG

Phase II results for AiCuris' novel non-nucleosidic herpes simplex virus (HSV) inhibitor AIC316 reveal safety and efficacy in persons with genital herpes. The data...

LEDON OLED Lighting presents the world most powerful OLED lighting module with 1001 lumen and new product lines on the OLED Lighting Design Summit

, Optische Technologien, LEDON OLED Lighting GmbH & Co. KG

Dresden/Germany – On the OLED Lighting Design Summit 2011 in London LEDON OLED Lighting will present a breakthrough in OLED Lighting, the first 1001 lumen lighting...

Honeywell's New Low-Global-Warming Refrigerant Approved by U.S. Environmental Protection Agency for Use in Cars

, FirmenIntern, Honeywell Specialty Chemicals Seelze GmbH

Honeywell (NYSE: HON) announced today that its new low-global-warming refrigerant for use in automobile air conditioning systems has received final approval from...

Protagen to Apply UNIarray® Platform for Biogen Idec

, Medizintechnik, Protagen AG

Protagen AG, a specialist in in-vitro diagnostics and GMP-compliant protein analysis announced today that they will be using the UNIarray® Platform to help discover...

Using Roche's CASY Cell Counter and Analyzer for proliferation and viability measurement in cancer studies

, Forschung und Entwicklung, Roche Diagnostics GmbH

In a recent study (1), Prokop et al. used the CASY Cell Counter and Analyzer from Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) to identify the specific anticancer...

AiCuris completes Phase II genital herpes trial with AIC316 ahead of time

, Forschung und Entwicklung, AiCuris GmbH & Co. KG

AiCuris announced today that the last subject has completed their Phase-II trial "A double-blind randomized placebo controlled dose-finding trial to investigate...

AiCuris Presents Preclinical and Phase 1 Data of its anti-HSV drug AIC316

, Forschung und Entwicklung, AiCuris GmbH & Co. KG

AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th - 9th of November...

Vivo Biosciences, ACEA Biosciences, and Roche to develop new xCELLigence System assays for stem cell and cancer research

, Biotechnik, Roche Diagnostics GmbH

ACEA Biosciences Inc. (San Diego, CA) and Vivo Biosciences Inc. (Birmingham, AL, US) announced that they have entered into a collaboration for the further development...

Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System

, Biotechnik, Roche Diagnostics GmbH

Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic side...

vorherige Seite vorherige Seite 123 nächste Seite nächste Seite
Ergebnisse 1 - 15 von 42

Ähnliche Keywords